ValuEngine upgraded shares of NutriSystem (NASDAQ:NTRI) from a strong sell rating to a sell rating in a report issued on Friday.

Other equities analysts have also issued reports about the stock. Zacks Investment Research raised shares of NutriSystem from a hold rating to a buy rating and set a $45.00 target price for the company in a research note on Thursday, August 2nd. B. Riley upped their target price on shares of NutriSystem from $52.00 to $53.00 and gave the stock a buy rating in a research note on Tuesday, July 31st. Citigroup upped their target price on shares of NutriSystem from $39.00 to $43.00 and gave the stock a buy rating in a research note on Thursday, June 14th. Barrington Research reaffirmed a hold rating on shares of NutriSystem in a research note on Friday, October 5th. Finally, BidaskClub raised shares of NutriSystem from a sell rating to a hold rating in a research note on Thursday, June 21st. One analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Hold and a consensus target price of $46.50.

NASDAQ NTRI traded up $1.09 on Friday, reaching $37.10. The company had a trading volume of 771,983 shares, compared to its average volume of 820,897. The firm has a market cap of $1.09 billion, a PE ratio of 18.93, a PEG ratio of 1.78 and a beta of 1.27. NutriSystem has a 1-year low of $26.06 and a 1-year high of $60.80.

NutriSystem (NASDAQ:NTRI) last announced its earnings results on Monday, July 30th. The company reported $0.87 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.06. The firm had revenue of $191.30 million during the quarter, compared to analyst estimates of $189.07 million. NutriSystem had a net margin of 7.94% and a return on equity of 43.29%. The company’s revenue for the quarter was down 1.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.80 EPS. Analysts expect that NutriSystem will post 2.09 earnings per share for the current fiscal year.

Institutional investors have recently bought and sold shares of the company. Atria Investments LLC acquired a new position in shares of NutriSystem during the 2nd quarter worth about $394,000. First Mercantile Trust Co. acquired a new position in shares of NutriSystem during the 2nd quarter worth about $119,000. Aperio Group LLC acquired a new position in shares of NutriSystem during the 2nd quarter worth about $313,000. Guggenheim Capital LLC boosted its stake in shares of NutriSystem by 8.3% during the 1st quarter. Guggenheim Capital LLC now owns 56,018 shares of the company’s stock worth $1,509,000 after buying an additional 4,308 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of NutriSystem during the 2nd quarter worth about $259,000.

About NutriSystem

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Featured Article: Stock Symbol

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.